Capricor Therapeutics (CAPR) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Capricor Therapeutics (CAPR) over the last 17 years, with Q3 2025 value amounting to $1.7 million.
- Capricor Therapeutics' Interest & Investment Income rose 27812.9% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 13603.25%. This contributed to the annual value of $2.2 million for FY2024, which is 2743.62% up from last year.
- Capricor Therapeutics' Interest & Investment Income amounted to $1.7 million in Q3 2025, which was up 27812.9% from $1.8 million recorded in Q2 2025.
- Over the past 5 years, Capricor Therapeutics' Interest & Investment Income peaked at $1.8 million during Q2 2025, and registered a low of $9165.0 during Q1 2021.
- Its 5-year average for Interest & Investment Income is $498896.0, with a median of $434320.5 in 2023.
- Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 5960.78% in 2021, then skyrocketed by 227549.42% in 2022.
- Over the past 5 years, Capricor Therapeutics' Interest & Investment Income (Quarter) stood at $15984.0 in 2021, then surged by 2275.49% to $379699.0 in 2022, then grew by 19.09% to $452199.0 in 2023, then surged by 51.83% to $686572.0 in 2024, then skyrocketed by 149.57% to $1.7 million in 2025.
- Its last three reported values are $1.7 million in Q3 2025, $1.8 million for Q2 2025, and $686572.0 during Q4 2024.